Study for the Development of Outcome Measures for Hidradenitis Suppurativa (ReVAMP)
Study PI: Joslyn Sciacca Kirby, MD, Penn State University, Penn State Milton S. Hershey Medical Center
Project Summary: The purpose of this 4-year study is to develop validated patient- and clinician-reported outcome measures for hidradenitis suppurativa (HS) to improve the way HS outcomes are measured.
Study Design: Mixed methods including focus groups, cross-sectional methods, and a prospective study will be used through the course of this study.
PaTH Partners: pending
Sponsor: Agency for Healthcare Research and Quality